Munich School of BioEngineering

The Munich School of BioEngineering (MSB) is an interdisciplinary research center within the Technical University of Munich (TUM) in Germany.


Research

At the MSB, researchers specializing in medicine, the natural sciences, and engineering join forces to develop new methods for diagnosing or treating diseases and improved technologies that compensate for physical disabilities. The activities cover the whole development process – beginning with the study of basic scientific principles and ending with their application in new medical devices, medicines, and software programs. Read more


Study

On both the Master's and the doctoral level, the MSB provides a variety of options for an interdisciplinary education in bioengineering, biomedical engineering, medical physics, medical informatics and related fields. More information is available on the page of the master's program “Biomedical Engineering and Medical Physics“ as well as on the overview pages for the master's programs and doctoral studies.


Entrepreneurship

The MSB actively supports researchers who want to start a business and turn their findings into innovative products and services. Read more


News

  • Prof. Thomas Misgeld is the director at the TUM Institute of Neuronal Cell Biology and coordinator for the SyNergy Cluster of Excellence. Image: ediundsepp

    Immune cells attack synapses

    27 January 2021 | Damage to the brain gray matter plays an important role in the progression of multiple sclerosis. A team of neuroscientists has now shown that the cause are inflammatory responses that lead to synapse loss, reducing neuronal activity. 

  • Prof. Karampinos and members of his research group (Image: private)

    Dimitrios Karampions is awarded the TUM Supervisory Award 2020

    4 December 2020 | Dimitrios Karampinos, Professor for Experimental Magnetic Resonance Imaging at TUM and Principal Investigator at MSB was award the TUM Supervisory award 2020 for outstanding supervision and education of his doctoral candidates in yesterday’s virtual Dies Academicus.